Analysts Anticipate Phibro Animal Health Corp (PAHC) to Post $0.43 Earnings Per Share

Wall Street brokerages expect Phibro Animal Health Corp (NASDAQ:PAHC) to post $0.43 earnings per share (EPS) for the current quarter, Zacks reports. Zero analysts have issued estimates for Phibro Animal Health’s earnings. Phibro Animal Health posted earnings per share of $0.44 in the same quarter last year, which would indicate a negative year over year growth rate of 2.3%. The business is expected to issue its next earnings results on Monday, February 4th.

According to Zacks, analysts expect that Phibro Animal Health will report full year earnings of $1.72 per share for the current fiscal year, with EPS estimates ranging from $1.69 to $1.74. For the next financial year, analysts forecast that the business will report earnings of $1.77 per share, with EPS estimates ranging from $1.70 to $1.84. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side research analysts that cover Phibro Animal Health.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings data on Tuesday, November 6th. The company reported $0.39 EPS for the quarter, missing the Zacks’ consensus estimate of $0.42 by ($0.03). The company had revenue of $200.20 million for the quarter, compared to analyst estimates of $203.99 million. Phibro Animal Health had a net margin of 7.89% and a return on equity of 38.91%. Phibro Animal Health’s revenue was up 3.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.38 EPS.

PAHC has been the subject of a number of research reports. BidaskClub raised shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research note on Wednesday, August 8th. Morgan Stanley boosted their target price on shares of Phibro Animal Health from $36.00 to $46.00 and gave the stock an “underweight” rating in a research report on Wednesday, August 29th. Zacks Investment Research lowered shares of Phibro Animal Health from a “hold” rating to a “sell” rating in a research report on Wednesday, August 29th. Finally, ValuEngine downgraded shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a report on Monday, November 12th. Three equities research analysts have rated the stock with a sell rating and three have issued a hold rating to the company. The company currently has an average rating of “Hold” and an average target price of $43.50.

NASDAQ PAHC opened at $33.54 on Friday. Phibro Animal Health has a twelve month low of $32.05 and a twelve month high of $54.62. The company has a debt-to-equity ratio of 1.62, a quick ratio of 1.82 and a current ratio of 3.26. The company has a market cap of $1.38 billion, a price-to-earnings ratio of 19.28, a PEG ratio of 2.93 and a beta of 0.82.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 19th. Shareholders of record on Wednesday, November 28th will be paid a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 1.43%. The ex-dividend date of this dividend is Tuesday, November 27th. This is an increase from Phibro Animal Health’s previous quarterly dividend of $0.10. Phibro Animal Health’s dividend payout ratio is presently 22.99%.

In related news, insider Dean J. Warras sold 10,000 shares of the firm’s stock in a transaction on Thursday, November 1st. The shares were sold at an average price of $42.84, for a total value of $428,400.00. Following the completion of the transaction, the insider now owns 10,000 shares of the company’s stock, valued at $428,400. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Jack Bendheim sold 20,000 shares of the firm’s stock in a transaction on Thursday, September 6th. The shares were sold at an average price of $47.14, for a total transaction of $942,800.00. The disclosure for this sale can be found here. Insiders sold 43,020 shares of company stock valued at $1,978,371 in the last ninety days. Insiders own 50.29% of the company’s stock.

Hedge funds have recently made changes to their positions in the business. Morgan Stanley lifted its stake in shares of Phibro Animal Health by 89.8% during the 3rd quarter. Morgan Stanley now owns 362,872 shares of the company’s stock worth $15,567,000 after buying an additional 171,639 shares during the last quarter. Legal & General Group Plc increased its holdings in Phibro Animal Health by 10.7% in the 3rd quarter. Legal & General Group Plc now owns 43,295 shares of the company’s stock valued at $1,852,000 after buying an additional 4,188 shares during the period. TIAA CREF Investment Management LLC increased its holdings in Phibro Animal Health by 10.1% in the 3rd quarter. TIAA CREF Investment Management LLC now owns 224,815 shares of the company’s stock valued at $9,645,000 after buying an additional 20,562 shares during the period. MetLife Investment Advisors LLC increased its holdings in Phibro Animal Health by 51.1% in the 3rd quarter. MetLife Investment Advisors LLC now owns 15,103 shares of the company’s stock valued at $648,000 after buying an additional 5,110 shares during the period. Finally, Man Group plc increased its holdings in Phibro Animal Health by 8.0% in the 3rd quarter. Man Group plc now owns 162,046 shares of the company’s stock valued at $6,952,000 after buying an additional 12,040 shares during the period. Hedge funds and other institutional investors own 48.33% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.

Further Reading: Stop Order Uses For Individual Investors

Get a free copy of the Zacks research report on Phibro Animal Health (PAHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply